Posted in | News | Petrochemicals

Kurdestan Petrochemical Selects Basell Technology for New LDPE Plant in Iran

Kurdestan Petrochemical Company, an affiliate of Iran’s National Petrochemical Company (NPC), has selected Basell’s Lupotech T technology for a new LDPE plant it intends to build in Sanandaj in Kurdestan province, Iran. The plant will have an annual capacity of 300 KT and start-up is planned for 2008.

Tecnimont of Italy was selected as the EPC contractor for the new plant, together with PIDEC of Iran.

The new plant will be part of NPC’s 11th Olefin project. Ethylene feedstock will be supplied from an ethane gas cracker located at Al Assaluyeh. A 1500 kilometre pipeline will connect the cracker with five petrochemical sites located in the western provinces of Iran.

In addition to the new Lupotech T plant, the 11th Olefin project includes a 300 KT per year HDPE Hostalen plant licensed by Basell, as well as two 300 KT per year LLDPE / HDPE plants.

“The Middle East, with all of the new projects being implemented, is destined to become the most important centre for polyolefin production, and NPC of Iran, together with its affiliates, will be one of the most important producers,” said Just Jansz, president of Basell’s Technology Business. “We are very pleased to have been selected by NPC and Kurdestan Petrochemical to supply technology for this and other important projects in Iran.”

This latest Lupotech T license is the 13th license granted by Basell for projects in Iran. The 13 licenses represent a combined annual capacity of over 3.1 million tones. Other technologies licensed by Basell in Iran include Spherilene, Lupotech G and Hostalen polyethylene technologies; and Spheripol, the world’s most widely used polypropylene technology.

http://www.basell.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.